Chemistry and stability of thiol based polyethylene glycol surface coatings on colloidal gold and their relationship to protein adsorption and clearance in vivo

Nanomaterials have presented a wide range of novel biomedical applications, with particular emphasis placed on advances in imaging and treatment delivery. Of the many particulate nanomaterials researched for biomedical applications, gold is one of the most widely used. Colloidal gold has been of great interest due to its chemical inertness and its ability to perform multiple functions, such as drug delivery, localized heating of tissues (hyperthermia), and imaging (as a contrast agent). It is also readily functionalized through the use of thiols, which spontaneously form sulfur to gold bonds with the surface. Polyethylene glycol (PEG) is the most widely used coating material for these particles as it provides both steric stability to the suspension and protein resistance. These properties extend the circulation time of the particles in blood, and consequently the efficacy of the treatment. Despite widespread use of PEG coated gold particles, the coating chemistry and stability of these particles are largely unknown. The goal of this work was to identify the mechanisms leading to degradation and stability of thiol based polyethylene glycol coatings on gold particles and to relate this behavior to protein adsorption and clearance in vivo. The results indicate that the protective PEG coating is susceptible to sources of oxidation (including dissolved oxygen) and competing adsorbates, among other factors. The quality of commercially available thiolated PEG reagents was also found to play a key role in the quality and protein resistance of the final PEG coating. Analysis of the stability of these coatings indicated that they rapidly degrade under physiological conditions, leading to the onset of protein adsorption when exposed to plasma or blood. Paralleling the protein adsorption behavior and onset of coating degradation observed in vitro, blood clearance of parenterally administered PEG coated particles in mice began after approximately 2h of circulation time. Taken together, the data presented in this work indicates that the stability of the PEG coating and the many factors affecting it represent a fundamental limitation to the use of these particles.